£2
No changevs Feb 2025Active13227017Private limited companyKingston Upon Thames
INOVAPHARM LIMITED
Significant control: Stephen Lawrence Atkin (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Inovapharm Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Inovapharm Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
INOVAPHARM LIMITED is an active private limited company (company number 13227017) incorporated on 25 February 2021, registered in Kingston Upon Thames. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 21 February 2026, showing net assets of £2. Net assets were unchanged on the prior period.
Peer position · net assets
By net assets it sits in the lower half of 151 comparable companies in Greater London (median £200, upper quartile £53k).
02
Ownership and control
- Stephen Lawrence Atkin
- owns 25–50% of shares
- holds 25–50% of voting rights
- Alexandra Butler
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 25 February 20215 yrs ago
- Next accounts due
- 21 November 2027in 390 days
- Confirmation statement due
- 11 March 2027in 135 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not reported
Not reported
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 21 February 2026 | £2 | — | — | — | — | — | — |
| 28 February 2025 | £2 | — | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £2 at 21 February 2026
- Incorporated five or more years agoIncorporated 25 February 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 390 days
- Confirmation statement duein 135 days
- Accounts period endNet assets £2 · dormant accounts
- Accounts period endNet assets £2 · dormant accounts
- Incorporated
08
Similar companies in Greater London
- OCANT BIOLOGICAL TECHNOLOGY CO., LTD.Beckenham · inc. Mar 2021
- OCULAR INTERFACE LIMITEDOrpington · inc. Feb 2021
- UK ACADEME LTDThames Ditton · inc. Jan 2021
- SIBACHI RESEARCH LTDWoodford Green · inc. Apr 2021
- LOVEMAMI MEDICAL CENTERBeckenham · inc. Apr 2021
- GLYCOS BIOMEDICAL LTDWalton-On-Thames · inc. May 2021
All companies incorporated on 25 February 2021 · in Feb 2021.
09
Reminders for INOVAPHARM LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.